drugset / Trial / NCT04569799

Accuracy of Contrast-Enhanced Ultrasound for Hepatocellular Carcinoma Post TACE

NCT04569799

Phase 4 Completed 26 enrolled Milton S. Hershey Medical Center
NaSingle-groupOpen-labelOther

Summary

The purpose of this research study is to find out if a different type of imaging study called contrast enhanced ultrasound (CEUS) is as good as, or better than CT or MRI in patients diagnosed with hepatocellular carcinoma (HCC) after receiving TACE treatment

Timeline

Start
2020-10-14
Primary completion
2022-10-11
Completion
2022-10-11

Drugs

EvaluationDrugModalityDoseRoute
Background Lumason Diagnostic / imaging agent 2.4 ml